Skip to main content
SpringerLink
Log in

Pathophysiology and Management of Insomnia During Depression

  • Published:
Annals of Clinical Psychiatry

Abstract

Depressed patients often report problems sleeping, and epidemiologic evidence suggests that insomnia may precede the onset of depression. Insomnia is associated with marked impairment in quality of life and ability to function effectively. Many studies have indicated that patients with chronic sleep problems have impaired mood and that effective management of insomnia in depressed patients can markedly improve their depression. Diagnosis of insomnia is challenging because there can be many different causes and the clinical picture can be blurred by the presence of other psychiatric illnesses. Pharmacotherapy provides reliable and rapid relief from insomnia, whereas behavioral therapies help produce long-term improvement. For many years, benzodiazepines have been the mainstay of drug treatment for insomnia. However, these drugs have significant side effects, and tolerance and dependence have discouraged use. Many doctors use sedating antidepressants in low doses to treat chronic insomnia. However, there is little evidence supporting the efficacy of these agents, and many have adverse side effects, including impairment of sleep. The newer selective hypnotic drugs, including the imidazopyridines, may offer patients a better short-term alternative to benzodiazepines or sedating antidepressants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Katon W, Schulberg H: Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992; 14:237–247

    Google Scholar 

  2. Coyne JC, Fechner-Bates S, Schwenk TL: Prevalence, nature and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry 1994; 16:267–276

    Google Scholar 

  3. Katon W: The epidemiology of depression in medical care. Int J Psychiatry Med 1987; 17:93–112

    Google Scholar 

  4. Perez-Stable EJ, Miranda J, Munoz RF, Ying Y-W: Depression in medical outpatients: Underrecognition and misdiagnosis. Arch Intern Med 1990; 150:1083–1088

    Google Scholar 

  5. Winokur A, Reynolds CF: The effects of antidepressants and anxiolytics on sleep physiology. Primary Psychiatry 1994; November/December: 19–25

  6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994;320–327

    Google Scholar 

  7. Berger M, Lund R, Bronisch T, von Zerssen D: REM latency in neurotic and endogenous depression and the cholinergic REM induction test. Psychiatry Res 1983; 10:113–123

    Google Scholar 

  8. Bixler EO, Kales A, Soldatos CR, Kales JD, Healey S: Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979; 136:1257–1262

    Google Scholar 

  9. Mellinger GD, Balter MB, Uhlenhuth EH: Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985; 42:225–232

    Google Scholar 

  10. Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA 1989; 262:1479–1484

    Google Scholar 

  11. Frisoni GB, De Leo D, Rozzini R, Bernardini M, Della Buono M, Trabucchi M: Psychic correlates of sleep symptoms in the elderly. Int J Geriatric Psychiatry 1992; 7:891–898

    Google Scholar 

  12. Frederick T, Frerichs RR, Clark VA: Personal health habits and symptoms of depression at the community level. Prevent Med 1988; 17:173–182

    Google Scholar 

  13. Bliwise DL, King AC, Harris RB, Haskell WL: Prevalence of self-reported poor sleep in a healthy population aged 50–65, Soc Sci Med 1992; 34:49–55

    Google Scholar 

  14. Soldatos CR: Insomnia in relation to depression and anxiety: Epidemiologic considerations. J Psychosom Res 1994; 38:3–8

    Google Scholar 

  15. Breslau N, Roth T, Rosenthal L, Andreski P: Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biol Psychiatry 1996; 39:411–418

    Google Scholar 

  16. Kupfer DJ: Neurophysiological “markers”—-EEG sleep measures. J Psychiatr Res 1984; 18:467–475

    Google Scholar 

  17. Reynolds CF III, Kupfer DJ: Sleep research in affective illness: State of the art circa 1987. Sleep 1987; 10:199–215

    Google Scholar 

  18. Rush AJ, Erman MK, Giles DE, Schlesser MA, Carpenter G, Vasavada N, Roffwarg HP: Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry 1986; 43:878–884

    Google Scholar 

  19. Sharpley AL, Cowen PJ: Effect of pharmacologic treatments on sleep of depressed patients. Biol Psychiatry 1995; 37:85–98

    Google Scholar 

  20. Giles DE, Biggs MM, Rush AJ, Roffwarg HP: Risk factors in families of unipolar depression: Psychiatric illness and reduced REM latency. J Affect Disord 1988; 14:51–59

    Google Scholar 

  21. Taylor DP, Eison MS, Riblet LA, Temple DL Jr, Yevich JP, Smith DW: Selective 5-HT2 receptor blockade: Pharmacological studies of BMY 13754, a nontricyclic antidepressant candidate. Soc Neurosci Abstr 1982; 8:465

    Google Scholar 

  22. Ball EM: Sleep disorders in primary care. Compr Ther 1997; 23:25–30

    Google Scholar 

  23. Bond T, Wooten V: The etiology and management of insomnia. Va Med Q 1996; 123:254–255

    Google Scholar 

  24. Ware JC, Morewitz J: Diagnosis and treatment of insomnia and depression. J Clin Psychiatry 1991; 52:55–61

    Google Scholar 

  25. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed., Revised. Washington, DC: American Psychiatric Association; 1987:218–224

    Google Scholar 

  26. Reynolds CF, Shipley JE: Sleep in depressive disorders. In: Hales RE, Frances AJ, eds. Psychiatry Update: The American Psychiatric Association Annual Review, Vol. 4. Washington, DC: American Psychiatric Press; 1985:341–351

    Google Scholar 

  27. Gillin JC, Ancoli-Israel S, Erman M: Sleep and sleep-wake disorders. In: Tasman A, Kay J, Lieberman JA, Eds. Psychiatry, 2nd ed. Philadelphia: WB Saunders Co.; 1996:1217–1248

    Google Scholar 

  28. Wehr TA: Improvement of depression and triggering of mania by sleep deprivation. JAMA 1992; 267:548–551

    Google Scholar 

  29. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE Jr: Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 1992; 149:538–543

    Google Scholar 

  30. Ebert D, Feistel H, Barocka A, Kaschka W. Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res 1994; 55:101–109

    Google Scholar 

  31. Ho AP, Gillin JC, Buchsbaum MD, Wu JC, Abel L, Bunney WE Jr: Brain glucose metabolism during non-rapid eye movement in major depression: A positron emission tomography study. Arch Gen Psychiatry 1996; 53:645–652

    Google Scholar 

  32. Berger M, Riemann D, Krieg JC: Cholinergic drugs as diagnostic and therapeutic tools in affective disorders. Acta Psychiatr Scand Suppl 1991; 83:52–60

    Google Scholar 

  33. Gillin JC, Sutton L, Ruiz C, Kelsoe J, Dupont RM, Darko D, Risch SC, Golshan S, Janowsky D: The cholinergic rapid eye movement induction test with arecoline in depression. Arch Gen Psychiatry 1991; 48:264–270

    Google Scholar 

  34. Sharpley AL, Walsh AES, Cowen PJ: Nefazodone—-a novel antidepressant—-may increase REM sleep. Biol Psychiatry 1992; 31:1070–1073

    Google Scholar 

  35. Lawlor BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL, Sunderland T: A preliminary study of the effects of nighttime administration of the serotonin-agonist, m-CPP, on sleep architecture and behavior in healthy volunteers. Biol Psychiatry 1991; 29:281–286

    Google Scholar 

  36. Dingemanse J: Pharmacotherapy of insomnia: Practice and prospects. Pharm World Sci 1995; 17:67–75

    Google Scholar 

  37. Coleman RM, Roffwarg HP, Kennedy SG, Guilleminault C, Cinque J, Cohn MA, Karacan I, Kupfer DJ, Lemmi H, Miles LE, Orr WC, Phillips ER, Roth T, Sassin JF, Schmidt HS, Weitzman ED, Dement WC: Sleep-wake disorders based on a polysomnographic diagnosis. JAMA 1982; 247:997–1003

    Google Scholar 

  38. Armitage R, Yonkers K, Cole D, Rush AJ: A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 1997; 17:161–168

    Google Scholar 

  39. Hammond EC: Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 1964; 54:11–23

    Google Scholar 

  40. Rakel RE: Insomnia: Concerns of the family physician. J Fam Pract 1993; 36:551–558

    Google Scholar 

  41. Eaton WE, Badawi M, Melton B: Prodromes and precursors: Epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995; 152:967–972

    Google Scholar 

  42. The Gallup Organization: Sleep in America: A National Survey of U.S. Adults. Houston, TX: for the National Sleep Foundation; 1991

    Google Scholar 

  43. Bonnet MH, Arand DL: We are chronically sleep deprived. Sleep 1995; 18:908–911

    Google Scholar 

  44. Diagnostic Classification Steering Committee, Thorpy MJ, Chairman: ICSD—-International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association; 1990

    Google Scholar 

  45. Kupfer DJ, Reynolds CF: Management of insomnia. N Engl J Med 1997; 336:341–346

    Google Scholar 

  46. Coleman RM: Diagnosis, treatment, and follow-up of about 8,000 sleep/wake disorder patients. In: Guilleminault C, Lugaresi E, Eds. Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. New York: Raven Press; 1983:87–97

    Google Scholar 

  47. Hauri P: Primary insomnia. In: Kryger MH, Roth T, Dement WC, Eds. Principles and Practice of Sleep Medicine. Philadelphia: WB Saunders; 1989:442–447

    Google Scholar 

  48. Reynolds CF, Kupfer DJ: Sleep in depression. In: Williams RL, Karacan I, Moor CA, Eds. Sleep Disorders: Diagnosis and Treatment. New York: John Wiley & Sons; 1988:147–164

    Google Scholar 

  49. Becker PM, Jamieson AO, Brown WD: Insomnia: Use of a decision tree to assess and treat. Insomnia 1993; 93:66–85

    Google Scholar 

  50. Brunton SA: When your patient can't sleep. Fam Pract Recertification 1992; 14:149–170

    Google Scholar 

  51. Morin CM, Kwentus JA: Behavioral and pharmacological treatments for insomnia. Ann Behav Med 1988; 10:91–100

    Google Scholar 

  52. Morin CM, Colecchi C, Stone J, Sood R, Brink D: Behavioral and pharmacological therapies for late-life insomnia: A randomized control trial. JAMA 1999; 281:991–999

    Google Scholar 

  53. Pary R, Tobias CR, Webb WK, Lippmann SB: Treatment of insomnia, getting to the root of sleeping problems. Insomnia 1996; 100:195–210

    Google Scholar 

  54. Gregor KJ, Riley JA, Downing DK: Concomitant use of anxiolytics and hypnotics with selective serotonin reuptake inhibitors. Clin Ther 1996; 18:521–527

    Google Scholar 

  55. Rascati K: Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clin Ther 1995; 17:786–790

    Google Scholar 

  56. NIH Consensus Development Conference: Consensus Development Conference Summary: Drugs and Insomnia. Bethesda, MD: National Institutes of Health; 1984; 4(10):1–9

  57. Roth T, Roehrs TA: A review of the safety profiles of benzodiazepine hypnotics. J Clin Psychiatry 1991; 52:38–41

    Google Scholar 

  58. Livingston MG: Benzodiazepine dependence. Br J Hosp Med 1994; 51:281–286

    Google Scholar 

  59. Evans SM, Critchfield TS, Griffiths RR: Abuse liability assessment of anxiolytics/hypnotics: Rationale and laboratory lore. Br J Addict 1991; 86:1625–1632

    Google Scholar 

  60. Rosholm J-U, Hallas J, Gram LF: Concurrent use of more than one major psychotropic drug (polypharmacy) in outpatients—-a prescription database study. Br J Clin Pharmacol 1994; 37:533–538

    Google Scholar 

  61. Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ: Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant. J Affect Disord 1993; 28:179–188

    Google Scholar 

  62. Kuitunen T, Mattila MJ, Seppala T: Actions and interactions of hypnotics on human performance: Single doses of zopiclone, triazolam, and alcohol. Int Clin Psychopharmacol 1990; 5(suppl 2):115–130

    Google Scholar 

  63. Haefely W: Benzodiazepine receptor and ligands: Structural and functional differences. In: Hindmarch I, Beaumont G, Brandon S, Leonard BE, Eds. Benzodiazepines: Current Concepts. Chichester: John Wiley & Sons; 1990:1–18

    Google Scholar 

  64. Salvá P, Costa J: Clinical pharmacokinetics and pharmacodynamics of zolpidem. Clin Pharmacokinet 1995; 29:142–153

    Google Scholar 

  65. Hartmann PM: Drug treatment of insomnia: Indications and newer agents. Am Fam Physician 1995; 51:191–194

    Google Scholar 

  66. Brunner DP, Dijk DJ, Munch M, Borbely AA: Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl) 1991; 104:1–5

    Google Scholar 

  67. Zolpidem: A hypnotic with a difference? Drug Ther Bull 1995; 33:37–39

  68. Palminteri R, Narbonne G: Safety profile of zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL, Eds. Imidazopyridines in Sleep Disorders. New York: Raven Press; 1988:351–361

    Google Scholar 

  69. Crismon ML, Jermain DM: Sleep aid and stimulant products. In: Covington TR, Berardi RR, Young LL, Kendall SC, Hickey MJ, Eds. Handbook of Nonprescription Drugs. Washington, DC: American Pharmaceutical Association; 1996: 135–146

    Google Scholar 

  70. Gillin JC, Byerley WF: The diagnosis and management of insomnia. N Engl J Med 1990; 322:239–248

    Google Scholar 

  71. Roehrs T, Zwyghuizen-Doorenbos A, Roth T: Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramines, ethanol and placebo. Sleep 1993; 16:301–305

    Google Scholar 

  72. Gengo F, Gabos C, Miller JK: The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther 1989; 45:15–21

    Google Scholar 

  73. Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL: Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 1978; 23:375–382

    Google Scholar 

  74. Dolberg OT, Hirschmann S, Grunhaus L: Melatonin for the treatment of sleep disturbances in major depressive disorder. Am J Psychiatry 1998;155:1119–1121

    Google Scholar 

  75. Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DL: Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995; 57:552–558

    Google Scholar 

  76. Butler RN: A wake-up call for caution. If insomnia is the patient's problem, is over-the-counter melatonin the cure? Geriatrics 1996; 51:14–15

    Google Scholar 

  77. Middleton BA, Stone BM, Arendt J: Melatonin and fragmented sleep pattern. Lancet 1996; 348:551–552

    Google Scholar 

  78. Mendels J: Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients. J Clin Psychiatry 1994; 55:60–65

    Google Scholar 

  79. American Psychiatric Association: Physiologic dependence on benzodiazepines. In: Salzman C, Ed. Benzodiazepine Dependence, Toxicity, and Abuse: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1990:15–23

    Google Scholar 

  80. Cohn JB: Triazolam treatment of insomnia in depressed patients taking tricyclics. J Clin Psychiatry 1983; 44:401–406

    Google Scholar 

  81. Dominguez RA, Jacobson AF, Goldstein BJ, Steinbook RM: Comparison of triazolam and placebo in the treatment of insomnia in depressed patients. Curr Ther Res. 1984; 36:856–865

    Google Scholar 

  82. Vgontzas AN, Kales A, Bixler EO: Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics. Pharmacology 1995; 51:205–223

    Google Scholar 

  83. Kales A, Soldatos CR, Bixler EO, Kales JD: Rebound insomnia and rebound anxiety: A review. Pharmacology 1983; 26:121–137

    Google Scholar 

  84. Bixler EO, Kales A, Brubaker BH: Adverse reactions to benzodiazepine hypnotics: Spontaneous reporting system. Pharmacology 1987; 35:286–300

    Google Scholar 

  85. Smith WT, Londborg PD, Glaudin V, Painter JR: Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: A double-blind study. Am J Psychiatry 1998; 155:1339–1345

    Google Scholar 

  86. Allard S, Sainati S, Roth-Schechter B, Macintyre J: Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women. Drug Metab Dispos 1998; 26:617–622

    Google Scholar 

  87. Rosenberg R, Scharf M, Ware JC, Walsh JK: Zolpidem improves sleep of SSRI-treated depressed patients with persistent insomnia. Sleep 1998; 21:136

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, 3811 O'Hara Street, Pittsburgh, PA, 15213

    David J. Kupfer

Authors
  1. David J. Kupfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kupfer, D.J. Pathophysiology and Management of Insomnia During Depression. Ann Clin Psychiatry 11, 267–276 (1999). https://doi.org/10.1023/A:1022321731612

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022321731612

Search

Navigation